Barriers to disclosure of diagnoses and diagnostic testing in families affected by X-linked adrenoleukodystrophy
This cross-sectional study reveals significant gaps in family communication and testing for X-linked adrenoleukodystrophy, identifying that a substantial proportion of potentially affected family members remain uninformed or untested due to barriers such as limited disease knowledge, emotional factors, and relationship dynamics, thereby underscoring the need for healthcare providers to actively facilitate disclosure and testing in the absence of newborn screening.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Genetic conditions that run in families present a unique challenge: the person who first receives a diagnosis often becomes the only bridge to the health of their relatives. In many parts of the world, where newborn screening does not automatically check for these rare disorders at birth, the responsibility falls on the diagnosed individual to pass the news along. This is the case for X-linked adrenoleukodystrophy, a rare hereditary condition that affects the brain, nerves, and adrenal glands. The disease can range from mild, slow-progressing issues in adulthood to severe, life-threatening damage to the brain in children. While treatments exist that can stop the worst forms of the disease from getting worse, they only work if the condition is caught early, before symptoms appear. Because the gene responsible is passed down through families, knowing who else carries the mutation is vital. If a parent or sibling remains unaware of their risk, they cannot get tested, and their children might grow up without the chance for early intervention.
A team of researchers at Leipzig University Medical Center in Germany set out to understand why this crucial information sometimes fails to travel through families. They focused on 51 adults who had already been diagnosed with X-linked adrenoleukodystrophy. These individuals were not just patients; they were the key to a larger family network. The researchers spent hours with each participant, building detailed family trees that mapped out hundreds of relatives who might also carry the gene. Through careful interviews, the team asked these adults what they knew about the disease, how they felt about their family members, and whether they had shared the diagnosis with those who might be at risk. The goal was to see how many at-risk relatives remained in the dark and to uncover the reasons why some families stayed silent while others spoke up.
The results revealed a significant gap in communication and testing. Across the family trees of these 51 adults, there were 639 relatives who could potentially have the condition. Of these, more than 40 percent had never been tested for the disease. The situation was even more concerning regarding awareness: one in three of the diagnosed adults reported that at least one relative in their family did not even know they were at risk. In many families, the problem was not a lack of knowledge but a lack of action; in over 80 percent of the family trees, there was at least one relative who knew about the risk but had not yet undergone genetic testing. This silence meant that many people, including young boys who are at high risk for severe brain disease, were missing the window for early treatment.
The study found that the decision to share this life-altering news depended heavily on the nature of the relationship. People were far more likely to tell a family member if they felt emotionally close to them, saw them often, or lived nearby. The bond mattered more than the bloodline; a distant cousin who was a frequent visitor was more likely to be informed than a parent or grandparent with whom contact had been lost. When the diagnosed adults did speak up, their main motivation was usually to ensure that a relative could get a diagnosis and treatment if symptoms appeared. However, when they did not speak, the reasons were often rooted in uncertainty or distance. Many assumed someone else in the family had already told the relative, only to realize later that no one had. Others had simply lost touch with certain relatives long before their own diagnosis, making it impossible to pass the warning along.
A surprising finding was that a lack of understanding about how the disease is inherited played a major role in who remained uninformed. Some adults mistakenly believed that because the condition is linked to the X chromosome, only women could pass it on, forgetting that affected men pass the gene to all their daughters. This confusion led to situations where female carriers, who might appear healthy but could have sons at risk, were never told about their status. The researchers also noted that the longer a person had lived with the diagnosis, the more likely their relatives were to have been tested, suggesting that time and repeated conversations help. Yet, even after many years, knowledge about the disease did not always improve, and some patients still held incorrect ideas about who was at risk.
The study concludes that relying solely on families to spread the word is not enough, especially when relationships are strained or distant. The researchers suggest that doctors need to help patients understand exactly who is at risk and provide them with simple, clear information they can share with relatives they do not see often. They also point out that in countries without newborn screening, the system is currently missing too many people who could be helped. By improving how families communicate and ensuring that patients have the right tools to share their diagnosis, more at-risk individuals could be identified early, preventing severe disability and saving lives. The path forward involves not just medical treatment, but also bridging the emotional and informational gaps that keep families apart.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.